Imaging techniques, particularly molecular imaging, have contributed significantly to understanding the relationships between target engagement by psychotropic drugs on the one hand and clinical effects and side effects on the other. Especially for antipsychotics, positron emission tomography (PET) studies of target engagement belong to the standard development program of new drugs.
No takes yet. Share an insight, caveat, or question.
Gerhard Gründer (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: